Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022
Mon, March 14, 2022
Fri, March 11, 2022

Sumant Kulkarni Upgraded (ACAD) to Strong Buy and Increased Target to $31 on, Mar 16th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-31-on-mar-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Sumant Kulkarni of Canaccord Genuity, Upgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Strong Buy and Increased Target from $30 to $31 on, Mar 16th, 2022.

Sumant has made no other calls on ACAD in the last 4 months.



There are 11 other peers that have a rating on ACAD. Out of the 11 peers that are also analyzing ACAD, 6 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $24 on, Monday, March 7th, 2022
  • Vamil Divan of "Mizuho" Maintained at Hold with Decreased Target to $28 on, Thursday, March 3rd, 2022
  • Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $31 on, Tuesday, March 1st, 2022
  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold and Held Target at $28 on, Tuesday, December 21st, 2021
  • Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $23 on, Thursday, December 9th, 2021
  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $24 on, Tuesday, December 7th, 2021


These are the ratings of the 5 analyists that currently disagree with Sumant


  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $37 on, Thursday, March 10th, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $35 on, Tuesday, March 1st, 2022
  • Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $36 on, Wednesday, February 9th, 2022
  • Neena Bitritto-Garg of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $30 on, Wednesday, January 5th, 2022
  • Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $34 on, Tuesday, December 21st, 2021

Publication Contributing Sources